Dr. Siegfried Bialojan Background Skills Professional experience June 2, 2018 Dr. Siegfried Bialojan Head of EY Life Science Center in Mannheim, Germany Close collaboration with EY Global Life Science Center in New York/ Boston Sponsoring member of Bio Deutschland (German biotech industry association) Dr. Siegfried Bialojan Executive Director Ernst & Young GmbH Wirtschaftsprüfungsgesellschaft Theodor-Heuss-Anlage 2 68165 Mannheim Germany Tel +49 621 4208 11405 Mobile +49 160 9391 11405 Fax +49 621 4208 42102 Email siegfried.bialojan@de.ey.com Background Skills Professional experience Areas of expertise In depth life science industry experience (trends, strategies, processes) Experience in business assessment (technology, IP, product portfolio, market, competitiveness, regulatory compliance) Go-to-market and project execution support, primarily in M&A, due diligence, valuation as well as advisory projects Broad relationship network in life sciences industry (companies, investors and industry associations) Personal skills and competences Relationships and contacts to international pharma and biotech executives Strengths in relationship building and business development Structured and strategic thinking Project and team management Languages German – mother tongue English – fluent in writing and speaking French – good understanding, basic in speaking Role at EY In charge of life science knowledge platform (global life science database, team of scientists with industry experience) Conducting global industry surveys and annual life sciences industry analysis Providing input to EY´s biotech and medtech thought leadership reports Assisting advisory client projects as an industry expert (transactions, performance improvement, risk management, assurance) Prior to joining EY 14 years in the pharmaceutical industry BASF Pharma / Knoll AG, Abbott In various functions: drug discovery research, drug screening, drug development (ADME), R&D management Post-doc scientist at German Cancer Research Institute; Heidelberg cell biology research PhD from University of Heidelberg molecular biology, human medicine (medical school) Projects Annual EY thought leadership Reports German biotechnology report, global biotechnology report, global medical technology report International benchmark studies life science strategies for several European countries / regions Business assessments of European Life Science companies (pharma, biotech, medtech) technologies, product portfolio, market, business plan, business risks, compliance Transaction advisory support M&A, due diligence, valuation, purchase price allocation Business advisory support R&D portfolio management / operational excellence